Butterbur Benefits: What the Research Shows About This Herbal Remedy

Butterbur (Petasites hybridus) is a marsh plant native to Europe and parts of Asia and North America. It has been used in traditional herbal medicine for centuries — historically for headaches, fever, and respiratory complaints. Today, it's among the more studied functional herbs in Western supplement research, particularly in two areas: migraine prevention and allergic rhinitis (hay fever). Here's what the science generally shows, and why individual results vary considerably.

What Butterbur Is and How It's Thought to Work

The active compounds in butterbur roots, rhizomes, and leaves include petasins — specifically petasin and isopetasin. These compounds are thought to influence several biological pathways:

• Leukotriene and prostaglandin inhibition — both are inflammatory signaling molecules involved in allergic responses and pain
• Calcium channel modulation — potentially relevant to vascular changes associated with migraines
• Histamine activity — some research suggests butterbur may reduce histamine-related responses without the sedating effects of older antihistamines

This combination of mechanisms is why butterbur is studied across both neurological and allergic contexts, rather than fitting neatly into a single pharmacological category.

⚠️ Important safety note: Raw butterbur contains pyrrolizidine alkaloids (PAs) — naturally occurring compounds that are toxic to the liver and potentially carcinogenic. Supplements used in research are PA-free extracts, processed specifically to remove these compounds. This distinction is clinically significant and discussed further below.

What the Research Generally Shows

Migraine Prevention

Butterbur has received more clinical attention for migraine prevention than almost any other herbal supplement. Several randomized controlled trials — the strongest study design — have examined standardized PA-free butterbur extract (commonly sold as Petadolex) at doses typically ranging from 50 to 150 mg daily.

A notable study published in Neurology found that participants taking 75 mg twice daily experienced a meaningful reduction in migraine frequency compared to placebo. On the basis of this kind of evidence, the American Academy of Neurology and the American Headache Society previously gave butterbur a Level A evidence rating for migraine prevention — the highest level for complementary treatments. (This rating has since been revisited due to safety concerns, which is addressed below.)

The evidence for migraine prevention is among the strongest in herbal supplement research, though study sizes have generally been modest and longer-term data remain limited.

Allergic Rhinitis (Hay Fever) 🌿

Several clinical trials have compared PA-free butterbur extract to conventional antihistamines for seasonal allergies. Results from a Swiss trial published in BMJ found that butterbur extract performed comparably to cetirizine (a common non-drowsy antihistamine) for symptom relief — without the sedating effects.

Other studies have shown similar comparisons with fexofenadine. While these findings are promising, the research base remains smaller than for standard pharmaceutical antihistamines, and most trials have been short in duration.

Other Studied Areas

Butterbur has been explored in preliminary research for:

• Asthma and airway reactivity — small studies suggest some effect on bronchial responsiveness
• Bladder spasm symptoms — limited European research, not widely replicated
• Anxiety — early-stage research only; evidence is insufficient to draw conclusions

These areas lack the robust clinical trial evidence seen in the migraine and allergy literature.

The Safety Variable: PA-Free Matters Significantly

The most important variable with butterbur is product quality and PA content.

There have been case reports of liver injury associated with butterbur supplements — including some products that were marketed as PA-free but were found on testing to still contain pyrrolizidine alkaloids. This is why product sourcing, third-party testing, and transparency from manufacturers matter considerably.

The European Medicines Agency has cautioned about butterbur use due to PA concerns, and regulatory guidance varies by country.

Factors That Shape Individual Responses

Several variables influence how any individual might respond to butterbur:

• Liver health — given the PA risk profile, liver function is particularly relevant
• Medication interactions — cytochrome P450 enzyme pathways may be involved; interactions with drugs metabolized by the liver are plausible
• Age — most clinical trials involved adults; safety data in children and older adults is more limited
• Allergy profile — individuals with ragweed, chrysanthemum, marigold, or daisy sensitivities may be more likely to react to butterbur, as it belongs to the same plant family (Asteraceae)
• Pregnancy and breastfeeding — safety data is insufficient; this population is generally excluded from butterbur studies
• Duration of use — most trials ran 12–16 weeks; long-term safety data is limited

What the Evidence Doesn't Settle

Butterbur sits in an unusual position among herbal supplements: it has more credible clinical trial data behind it than most, particularly for migraines — and yet it carries genuine safety considerations that make individual circumstances especially important. The strength of the evidence and the nature of the risk profile both depend heavily on the specific extract used, the dose, the duration, and the individual's health status. Whether that balance makes sense for any particular person depends on factors the research alone can't answer.